Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor site update.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s release rather than any study-specific information.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:44.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.0.0? to v3.5.2 on the page. This appears to be a minor maintenance update with no impact on content or functionality.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:55.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added the indexing term 'Mucopolysaccharidosis, MPS-II' and removed 'Mucopolysaccharidosis type 2' from the study's terminology list.
    Difference
    0.1%
    Check dated 2026-03-26T11:26:44.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:33:28.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The displayed revision changed from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:47:49.000Z thumbnail image

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.